Replimune (REPL) Net Equity Issued and Repurchased (2019 - 2026)

Replimune (REPL) has 7 years of Net Equity Issued and Repurchased data on file, last reported at -$10.4 million in Q1 2026.

• For the quarter ending Q1 2026, Net Equity Issued and Repurchased changed N/A year-over-year to -$10.4 million; the trailing twelve-month figure through Dec 2025 stood at $10.4 million (changed N/A YoY), and the FY2023 full-year result was $149.9 million, changed N/A from the prior year.
• Net Equity Issued and Repurchased fell to -$10.4 million in Q1 2026, from $10.4 million in the prior quarter.
• In the past five years, Net Equity Issued and Repurchased ranged from a high of $242.6 million in Q4 2022 to a low of -$48.2 million in Q4 2024.
• A 5-year average of $35.0 million and a median of $8.5 million in 2022 frame the typical range for Net Equity Issued and Repurchased.
• Peak annual rise in Net Equity Issued and Repurchased reached 121.5% in 2025, while the deepest fall reached 121.5% in 2025.
• Tracing REPL's Net Equity Issued and Repurchased over 5 years: stood at $242.6 million in 2022, then plunged by 100.1% to -$248000.0 in 2023, then slumped by 19337.1% to -$48.2 million in 2024, then jumped by 121.5% to $10.4 million in 2025, then tumbled by 200.0% to -$10.4 million in 2026.
• Business Quant data shows REPL's Net Equity Issued and Repurchased at -$10.4 million in Q1 2026, $10.4 million in Q4 2025, and -$48.2 million in Q4 2024.